Snyder Biomedical

Business Services · Arizona, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

4711 E Camp Lowell Dr, Tucson, Arizona, ...

Phone Number

(520) 327-2020

Revenue

<$5 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1

About Snyder Biomedical

Snyder Biomedical Corporation, founded in 2008 by Dr. Robert W. Snyder and John A. Martens, focuses on innovative therapies to treat and prevent blinding eye diseases, particularly age-related macular degeneration (AMD). The company is developing L-DOPA as a potential adjunct treatment for neovascular AMD, aiming to reduce the need for costly anti-VEGF injections. Their research has shown promising results in clinical trials, indicating improvements in vision and a significant decrease in injection frequency. Snyder Biomedical is actively seeking pharmaceutical partners to further advance their research and clinical trials.Explore more
Snyder Biomedical's Social MediaPopular SearchesSnyder Biomedical CorpSnyder Building LLCSnyder BiomedicalSnyder Biomedical holdsSnyderbiomedicalSIC Code 87,873NAICS Code 54,541Show more

Is Snyder Biomedical your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Snyder Biomedical

Compare insights from companies similar to Snyder Biomedical, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Snyder Biomedical

<$5M
11-50
Private
-
2008
N/A
$17.4M
51-200
Private
-
2000
AK
Alex KimDirector
<$5M
11-50
Private
-
-
WM
William McVicarExecutive Vice President & Scientific Chief & Officer
<$5M
11-50
Public
$104.6M
2012
George Lasezkay, President & Chief Executive Officer at Clearside BioMedical
George LasezkayPresident & CEO
<$5M
1-10
Private
-
2012
51-200
Public
$476.4M
2009
John Borgeson, Chief Financial Officer at Kodiak Sciences
John BorgesonChief Financial Officer
1-10
Public
$77M
2004
TB
Todd BradyCEO, President & Director
Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

Snyder Biomedical is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

Snyder Biomedical is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Snyder Biomedical.

Snyder Biomedical Tech Stack

A closer look at the technologies used by Snyder Biomedical

Top Business Services Companies

Frequently Asked Questions Regarding Snyder Biomedical

What is Snyder Biomedical's official website?
Snyder Biomedical's official website is www.snyderbiomedical.com
What is Snyder Biomedical's Revenue?
Snyder Biomedical's revenue is <$5 Million
What is Snyder Biomedical's SIC code?
Snyder Biomedical's SIC: 87,873
What is Snyder Biomedical's NAICS code?
Snyder Biomedical's NAICS: 54,541
How many employees does Snyder Biomedical have?
Snyder Biomedical has 11-50 employees
What industry does Snyder Biomedical belong to?
Snyder Biomedical is in the industry of: Business Services, Research & Development
What is Snyder Biomedical competition?
Snyder Biomedical top competitors include: jCyte, Clearside BioMedical, Inotek Pharmaceuticals, Kodiak Sciences
What technology does Snyder Biomedical use?
Some of the popular technologies that Snyder Biomedical uses are: Squarespace Online Stores, Adobe Typekit, Google Workspace, Gmail
How do I contact Snyder Biomedical?
Snyder Biomedical contact info: Phone number: (520) 327-2020 Website: www.snyderbiomedical.com
What does Snyder Biomedical do?

Snyder Biomedical Corporation, founded in 2008 by Dr. Robert W. Snyder and John A. Martens, focuses on innovative therapies to treat and prevent blinding eye diseases, particularly age-related macular degeneration (AMD). The company is developing L-DOPA as a potential adjunct treatment for neovascular AMD, aiming to reduce the need for costly anti-... VEGF injections. Their research has shown promising results in clinical trials, indicating improvements in vision and a significant decrease in injection frequency. Snyder Biomedical is actively seeking pharmaceutical partners to further advance their research and clinical trials.Read More

What are Snyder Biomedical social media links?
Snyder Biomedical Linkedin page
Is Snyder Biomedical a public company?
Snyder Biomedical is private company therefore does not currently have an official ticker symbol
See more information about Snyder Biomedical

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.